Kuros reports Corporate Highlights as of Q1 2024 including i

Kuros Biosciences AG Key word Quarter ResultsRegulatory Approval Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales 24Apr2024 0700 CETCEST Release of an ad

Related Keywords

Switzerland , Zurich , Züsz , Kuros Biosciences , Leadership Team , Drug Administration , Business Development , Kuros Medical Devices , Magnetos Putty , Joe Ross , Senior Vice President , Chris Fair , Kuros , Iosciences , Quarter , Esultsregulatory , Approval , Reports , Corporate , Highlights , Ncluding , Increase , Direct , Agnetostm , Sales , Etcest , Release , Announcement , Ursuant , Ssuer , Olely , Esp ,